Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease

Journal of Neurochemistry

Volumn 70, Issue 1, 1998, Pages 1-14

  Mattson, Mark P ^a,b   Guo, Qing ^a   Furukawa, Katsutoshi ^a   Pedersen, Ward A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyloid precursor protein; Amyloid peptide; Apoptosis; Calcium homeostasis; Inositol trisphosphate; Muscarinic cholinergic; Nerve growth factor; Reactive oxygen species; Vitamin E

Indexed keywords

AMYLOID BETA PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT DISORDER; CALCIUM HOMEOSTASIS; CHROMOSOME 1; CHROMOSOME 14; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROTOXICITY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; REVIEW;

MUS MUSCULUS;

EID: 0031982670     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70010001.x     Document Type: Review

References (111)

1. Barger S. W. and Mattson M. P. (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40, 116-126.
2. Bartus R. T., Dean R. L., Beer B., and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 214, 408-417.
3. Benzi G. and Moretti A. (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16, 661-674.
4. Berezovska O., Xia M. Q., Page K., Wasco W., Tanzi R. E., and Hyman B. T. (1997) Developmental regulation of presenilin mRNA expression parallels notch expression. J. Neuropathol. Exp. Neurol. 56, 40-44.
5. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., and Sisodia S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
6. Boteva K., Vitek M., Mitsuda H., de Silva H., Xu P. T., Small G., and Gilbert J. R. (1996) Mutation analysis of presenilin 1 gene in Alzheimer's disease. Lancet 347, 130-131.
7. Bouras C., Giannakopoulos P., Schioi J., Tezapsidis N., and Robakis N. K. (1996) Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347, 1185-1186.
8. Bowling A. C. and Beal M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
9. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B., Staufenbiel M., and Yankner B. A. (1997) Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17, 5101-5107.
10. Campion D., Flaman J. M., Brice A., Mannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., and Tardieu S. (1995) Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4, 2373-2377.
11. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De La Sayette V., Mannequin D., Duyckaerts C., Michon A., Martin C., Moreau V., Penet C., Martinez M., Clerget-Darpoux F., Agid Y., and Frebourg T. (1996) A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 7, 1582-1584.
12. Conlon R. A., Reaume A. G., and Rossant J. (1995) Notch1 is required for the coordinate segmentation of somites. Development 121, 1533-1545.
13. Cook D. B., Sung J. C., Golde T. E., Felsenstein K. M., Wojczyk B. S., Tanzi R. E., Trojanowski J. Q., Lee V. M. Y., and Doms R. W. (1996) Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93, 9223-9228.
14. Cribbs D. H., Chen L., Bendle S. M., and La Ferla F. M. (1996) Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease in the murine brain. Am. J. Pathol 148, 1797-1806.
15. Cruts M., Backhovens H., Wang S. Y., Gassen G. V., Theuns J., De Jonghe C. D., Wehnert A., De Voecht J., De Winter G., and Cras P. (1995) Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4, 2363-2371.
16. Deng G., Pike C. J., and Cotman C. W. (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397, 50-54.
17. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., St. George-Hyslop P., and Van Leuven F. (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272, 3590-3598.
18. Dewji N. N. and Singer S. J. (1996) Specific transcellular binding between membrane proteins crucial to Alzheimer disease. Proc. Natl. Acad. Sci. USA 93, 12575-12580.
19. Doan A., Thinakaran G., Borchelt D. R., Slum H. H., Ratovitsky T., Podlisny M., Selkoe D. J., Seeger M., Gandy S. E., Price D. L., and Sisodia S. S. (1996) Protein topology of presenilin 1. Neuron 17, 1023-1030.
20. Duff K., Eckman C., Zehr C., Yu X., Prada C-M., Perez-Tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., and Younkin S. (1996) Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
21. Elder G. A., Tezapsidis N., Carter J., Shioi J., Bouras C., Li D., Johnston J. M., Efthimiopoulos S., Friedrich V. L., and Robakis N. K. (1996) Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brains. J. Neurosci. Res. 45, 308-320.
22. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., and Mattson M. P. (1996) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
23. Gabuzda D., Busciglio J., Chen L., Matsudaira P., and Yankner B. A. (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
24. Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., and Fiori C. E. (1984) Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc. Natl. Acad. Sci. USA 81, 1875-1879.
25. Giannakopoulos P., Bouras C., Kovari E., Shioi J., Tezapsidis N., Hof P. R., and Robakis N. K. (1997) Presenilin-1 immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am. J. Parthol. 150, 429-436.
26. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N., Martin G. M., and Mattson M. P. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport 8, 379-383.
27. Guo G., Sopher B. L., Pham D. G., Furukawa K., Robinson N., Martin G. M., and Mattson M. P. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
28. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
29. Hartmann H., Busciglio J., Baumann K. H., Staufenbiel M., and Yankner B. A. (1997) Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272, 14505-14508.
30. Haug L. S., Ostvold A. C., Cowburn R. F., Garlind A., Winblad B., Bogdanovich N., and Walaas S. I. (1996) Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration 5, 169-176.
31. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 534-538.
32. Kamino K., Sato S., Sakaki Y., Yoshiiwa A., Nishiwaki Y., Takeda M., Tanabe H., Nishimura T., Ii K., St. George-Hyslop P. H., Miki T., and Ogihara T. (1996) Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families. Neurosci. Lett. 208, 195-198.
33. Kaneko Y. and Tsukamoto A. (1994) Thapsigargm-induced persistent intracellular calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett. 97, 147-155.
34. Kelly J. F. and Roth G. S. (1997) Changes in neurotransmitter signal transduction pathways in the aging brain, in The Aging Brain (Mattson M. P. and Geddes J. W., eds), JAI Press; Adv. Cell Aging Gerontol. 2, 243-278.
35. Kelly J. F. and Roth G. S. (1997) Changes in neurotransmitter signal transduction pathways in the aging brain, in The Aging Brain (Mattson M. P. and Geddes J. W., eds), JAI Press; Adv. Cell Aging Gerontol. 2, 243-278.
36. Khan A. A., Soloski M. J., Sharp A. H., Schilling G., Sabatini D. M., Li S. H., Ross C. A., and Snyder S. H. (1996) Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 273, 503-507.
37. Kim T.-W., Pettingell W. H., Jung Y.-K., Kovacs D. M., and Tanzi R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
38. Knudson C. M. and Korsmeyer S. J. (1997) Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16, 358-363.
39. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., and Wasco W. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2, 224-229.
40. Kruman I., Bruce-Keller A. J., Bredesen D. E., Waeg G., and Mattson M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5097-5108.
41. Kuznetsov G., Brostrom M. A., and Brostrom C. O. (1992) Demonstration of a calcium requirement for secretory protein processing and export. J. Biol. Chem. 267, 3932-3939.
42. Lah J. J., Heilman C. J., Nash N. R., Rees H. D., Yi H., Counts S. E., and Levey A. I. (1997) Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17, 1971-1980.
43. Leaman D. W., Leung S., Li X., and Stark G. R. (1996) Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10, 1578-1588.
44. Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo E., Price D. L., and Sisodia S. S. (1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16, 7513-7525.
45. Lehmann S., Chiesa R., and Harris D. A. (1997) Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272, 12047-12051.
46. Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
47. Levitan D., Doyle T. G., Brousseau D., Lee M. K., Thinakaran G., Slunt H. H., Sisodia S. S., and Greenwald I. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93, 14940-14944.
48. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A. B., Weber J. L., Bird T. D., and Schellenberg G. D. (1995a) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
49. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C-E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., and Tanzi R. E. (1995b) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
50. L'Hernault S. W. and Arduengo P. M. (1992) Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J. Cell Biol. 119, 55-68.
51. Li X. and Greenwald I. (1996) Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 1015-1021.
52. Liguri G., Cecchi C., Latorraca S., Pieri A., Sorbi S., Degl'Innocenti D., and Ramponi G. (1996) Alteration of acylphosphatase levels in familial Alzheimer's disease fibroblasts with presenilin gene mutations. Neurosci. Lett. 210, 153-156.
53. Lodish H. F. and Kong N. (1990) Perturbation of cellular calcium blocks exit of secretory proteins from the rough endoplasmic reticulum. J. Biol. Chem. 265, 10893-10899.
54. Loo D., Copani A., Pike C., Whittemore E., Walencewicz A., and Cotman C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
55. 2+. Oncogene 12, 2259-2266.
56. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
57. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997a) A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
58. Mark R. J., Pang Z., Geddes J. W., and Mattson M. P. (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
59. Mattson M. P. (1990) Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4, 105-117.
60. Mattson M. P. (1992) Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27, 29-49.
61. Mattson M. P. (1997a) Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77, 1081-1132.
62. Mattson M. P. (1997b) Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 20, 373-375.
63. Mattson M. P. (1997c) Free radicals, calcium, and the synaptic plasticity-cell death continuum: emerging roles of the transcription factor NF-κB. Int. Rev. Neurobiol. 42, 103-168.
64. Mattson M. P. and Furukawa K. (1996) Programmed cell life: anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders. Restorative Neurol. Neurosci. 9, 191-205.
65. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
66. Mattson M. P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254.
67. Mattson M. P., Furukawa K., Bruce A. J., Mark R. J., and Blanc E. M. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in Molecular Mechanisms of Dementia (Wasco W. and Tanzi R. E., eds). pp. 103-143. Humana Press, Totowa, New Jersey.
68. Mattson M. P., Mark R. J., and Furukawa K. (1997a) Oxidative disruption of ion homeostasis and cellular mechanisms of protection therefrom. Chem. Res. Toxicol. 10, 507-517.
69. Mattson M. P., Goodman Y., Luo H., Fu W., and Furukawa K. (1997b) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
70. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y., Noguchi K., Imahori K., and Takashirna A. (1996) Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389, 297-303.
71. Murphy G. M., Forno L. S., Ellis W. G., Nochlin D., Levy-Lahad E., Poorkaj P., Bird T. D., Jiang Z., and Cordell B. (1996) Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 149, 1839-1846.
72. Muthukkumar S., Nair P., Sells S. F., Maddiwar N. G., Jacob R. J., and Rangnekar V. M. (1995) Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol. Cell. Biol. 15, 6262-6272.
73. Nixon R. A., Saito K. I., Grynspan F., Griffin W. R., Katayama S., Honda T., Mohan P. S., Shea T. B., and Beermann M. (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747, 77-91.
74. Page K., Hollister R., Tanzi R. E., and Hyman B. T. (1996) In situ hybridization of presenilin 1 mRNA in Alzheimer's disease and lesioned rat brain. Proc. Natl. Acad. Sci. USA 93, 14020-14024.
75. Pedersen W., Guo Q., Hartman B. K., and Mattson M. P. (1997) NGF-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem. 272, 22397-22400.
76. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K., Wragg M., Busfield F., Lendon C., Clark R. F., Roques P., Fuldner R. A., Johnston J., Cowburn R., Forsell C., Axelman K., Lilius L., Houlden H., Karran E., Roberts G. W., Rossor M., Adams M. D., Hardy J., Goate A., Lannfelt L., and Hutton M. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297-301.
77. Querfurth H. W. and Selkoe D. J. (1994) Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33, 4550-4561.
78. Refolo L. M., Wittenberg L. Friedrich J., and Robakis N. K. (1991) The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J. Neurosci. 11, 3888-3897.
79. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorhi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
80. Rogaev E. I., Sherrington R., Wu C. Levesque G., Liang Y., Rogaeva E. A., Ikeda M., Holman K., Lin C., Lukiw W. J., de Jong P. J., Fraser P. E., Rommens J. M., and St. George-Hyslop P. (1997) Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene associated with early onset Alzheimer's disease. Genomics 40, 415-424.
81. Rossor M. N., Fox N. C., Beck J., Campbell T. C., and Collinge J. (1996) Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 347, 1560.
82. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
83. Seeger M., Nordstedt C., Petanceska S., Kovacs D. M., Gouras G. K., Hahne S., Frasier P., Levesque L., Czernik A. J., St. George-Hyslop P., Sisodia S. S., Thinakaran G., Tanzi R. E., Greengard P., and Gandy S. (1997) Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl. Acad. Sci. USA 94, 5090-5094.
84. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403.
85. Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J., and Tonegawa S. (1997) Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89, 629-639.
86. Sherrington R., Rogaev E. I. Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sansequ P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
87. Simons M., Ikonen E., Tienari P. J., Cid-Arregui A., Monning U., Beyreuther K., and Dotti C. G. (1995) Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J. Neurosci. Res. 41, 121-128.
88. Smale G., Nichols N. R., and Brady D. R. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133, 225-230.
89. Spacek J. and Harris K. M. (1997) Three-dimensional organization of smooth endoplasmic reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature rat. J. Neurosci. 17, 190-203.
90. Stein-Behrens B., Mattson M. P., Chang I., Yeh M., and Sapolsky R. M. (1994) Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373-5380.
91. St. George-Hyslop P. H., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J. F., Montesi M., Bruni A., Sorbi S., Rainero I., Pinessi L., Pollen D., Polinsky R., Nee L., Kennedy J., Macciardi F., Rogaeva E., Liang Y., Alexandrova N., Lukiw W., Schlumpf K., Tanzi R., Tsuda T., Farrer L., Cantu J.-M., Duara R., Amaducci L., Bergamini L., Gusella J., Roses A., and Crapper McLachlan D. (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat. Genet. 2, 330-334.
92. Su J. H., Anderson A. J., Cummings B., and Cotman C. W. (1994) Immunocytochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5, 2529-2533.
93. Suzuki T., Nishiyama K., Murayama S., Yamamoto A., Sato S., Kanazawa I., and Sakaki Y. (1996) Regional and cellular presenilin 1 gene expression in human and rat tissues. Biochem. Biophys. Res. Commun. 219, 708-713.
94. Tanahashi H., Kawakatsu S., Kaneko M., Yamanaka H., Takahashi K., and Tabira T. (1996) Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. Neurosci. Lett. 218, 139-141.
95. Tanzi R., Kovacs D. M., Kim T. W., Moir R. D., Guenette S. Y., and Wasco W. (1997) The presenilin genes and their role in early-onset familial Alzheimer's disease. Alzheimer's Dis. Rev. 1, 90-98.
96. Thinakaran G., Borchelt D. R., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Norstedt C., Seeger M., Hardy J., Levey A., Gandy S. E., Jenkins N. A., Copeland N. G., Price D. L., and Sisodia S. S. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
97. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
98. Tomita T., Maruyama K., Saido T. C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., and Obata K. (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer's disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94, 2025-2030.
99. Uchihara T., el Hachimi H. K., Duyckaerts C., Foncin J. F., Fraser P. E., Levesque L., St. George-Hyslop P. H., and Hauw J. J. (1996) Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: double-labeling immunohistochemical study. Acta Neuropathol. 92, 325-330.
100. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
101. Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacana E., and D'Adamio L. (1996b) Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271, 31025-31028.
102. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlinsy M. B., Fraser P., St. George-Hyslop P., Selkoe D. J., and Haass C. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691.
103. Weber L. L., Leissring M. A., Yang A. J., Glabe C. G., Cribbs D. H., and LaFerla F. M. (1997) Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques. Exp. Neurol 143, 37-44.
104. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C. L., and Beyreuther K. (1997) Formation of stable complexes between two Alzheimer's disease gene products, presenilin-2 and β-amyloid precursor protein. Nat. Med. 3, 328-332.
105. Williams R., Lendahl U., and Lardelli M. (1995) Complementary and combinatorial pattern of Notch gene family expression during early mouse development. Mech. Dev. 53, 357-368.
106. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W., and D'Adamio L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
107. Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J. S., Trumbauer M. E., Chen H. Y., Price D. L., Van der Ploeg L. H. T., and Sisodia S. S. (1997) Presenilin 1 is required for Notch 1 and Dll 1 expression in the paraxial mesoderm. Nature 387, 288-292.
108. Xia W., Zhang J., Perez R., Koo E. H., and Selkoe D. J. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94, 8208-8213.
109. Younkin S. (1995) Evidence that Aβ 42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37, 287-288.
110. Zhou J., Liyangage U., Medina M., Ho C., Simmons A. D., Lovett M., and Kosik K. S. (1997) Presenilin 1 interaction in the brain with a novel member of the armadillo family. Neuroreport 8, 1489-1494.
111. Zhu W., Cowie A., Wasfy G. W., Penn L. Z., Leber B., and Andrews D. W. (1996) Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15, 4130-4141.